ZLD

2.86%

72.0¢ zelira therapeutics limited

Dream big with Zelira, page-1133

First 1133 Last

Share
Profile

Follow
mattstambe

755 Posts.

186

24/07/21

09:45

Post #: 54738593
Share

Originally posted by Aussie Eagle: ↑

They're doing the most meaningful thing possible mate !
Expenditure on consultants fees and executives' salaries are all used to ensure any news releases and announcements are correctly punctuated to save the integrity of the written english language ! Lol

A reminder of your first post on ZLD back in Dec '19...
"My concerns with ZLD's planned products (e.g HOPE) are there is no commercial advantage for its product."

At that time (as now) your stated 'position' was 'Held'

If my own analysis came up with a 'no commercial advantage' then there isn't a chance in hell that I'd invest in them. So why did you ??
In fact, I very much doubt you have any monetary interest in them at all, unless you bought some on a mate's recommendation at a much higher sp than it is currently and regretting doing so ever since.

Your recent post saying "I don't get ZLD" and "What is the point of ZLD" rings a tone of regret but let me offer an opinion (not advice) to you that if you have been holding shares for a while now, ZLD have only started to establish themselves in the US and the MC laws there are beginning to loosen up, your investment will pay off in the next year or so.

I'd had Zelira/Zelda on my watchlist since 2017 and only chose recently to get a few because I'm very confident with the pathways they are forging.

Good luck with whatever your 'Hopes' are anyway and Hopefully you might share some research of your own with us.

Cheers, AE

Expand

unfortunately the same stuff they were spouting in 2019 still hasn't happened.

Product registration = 0
Revenues = close to 0
FDA open INDs open = 0
TGA product registrations = 0

if you stopped the incessant back slapping and high fiving you will realise that there isn't much going on here. Just another newsflow stock -

however, since Hopkins left, even the newsflow stopped!

What a waste of money....

IMHO GLTA DYOR

ZLD Price at posting: 4.7¢ Sentiment: None Disclosure: Held
5 Upvote

0 Great analysis

Reply

Top Stories

BCI

BCI reaches close of funding facility for salt-first part of Mardie project

ACW

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

BUX

Buxton projects new graphite province discovery at WA Narryer play

RCE

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

NTI

Neurotech knocked back by FDA as agency declares target condition not rare enough for special status

SLS

Solstice Minerals to ramp up drilling campaign at Yarri Gold Project

WCN

White Cliff jumps 24% on 'bonanza grade' copper rock chips at Rae project, Canada

Week 40 Wrap: China's nonsensical stimmy hype wanes (shocking!); HotCopper's picks; oil & inflation

COD

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

CKA

Cokal upgrades infrastructure for BBM ramp-up in Indonesia

There are more pages in this discussion • 65 more messages in this thread...

First 1133 Last

Add ZLD (ASX) to my watchlist

(20min delay)
Last 72.0¢		Change 0.020(2.86%)		Mkt cap ! $8.169M

Open	High	Low	Value	Volume
71.0¢	75.0¢	71.0¢	$2.142K	2.893K

Buyers (Bids)

No.	Vol.	Price($)
1	8	73.5¢

Sellers (Offers)

Price($)	Vol.	No.
80.0¢	466	1

View Market Depth

No.	Vol.	Price($)
1	8	0.735
1	1500	0.720
1	394	0.710
2	14488	0.700
2	2145	0.690

Price($)	Vol.	No.
0.800	466	1
0.940	40000	1
0.950	1429	1
0.980	1021	2
1.010	1000	1

Last trade - 13.49pm 04/10/2024 (20 minute delay)

ZLD (ASX) Chart

Dream big with Zelira, page-1133

BCI reaches close of funding facility for salt-first part of Mardie project

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

Buxton projects new graphite province discovery at WA Narryer play

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

Neurotech knocked back by FDA as agency declares target condition not rare enough for special status

Solstice Minerals to ramp up drilling campaign at Yarri Gold Project

White Cliff jumps 24% on 'bonanza grade' copper rock chips at Rae project, Canada

Week 40 Wrap: China's nonsensical stimmy hype wanes (shocking!); HotCopper's picks; oil & inflation

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

Cokal upgrades infrastructure for BBM ramp-up in Indonesia

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Dream big with Zelira, page-1133

Top Stories

BCI reaches close of funding facility for salt-first part of Mardie project

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

Buxton projects new graphite province discovery at WA Narryer play

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

Neurotech knocked back by FDA as agency declares target condition not rare enough for special status

Solstice Minerals to ramp up drilling campaign at Yarri Gold Project

White Cliff jumps 24% on 'bonanza grade' copper rock chips at Rae project, Canada

Week 40 Wrap: China's nonsensical stimmy hype wanes (shocking!); HotCopper's picks; oil & inflation

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

Cokal upgrades infrastructure for BBM ramp-up in Indonesia

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News